Background: Early detection of metabolic syndrome is highly desirable for the prevention and treatment of various diseases. Therefore, this study aimed to develop and validate an anthropometry-based nomogram for predicting metabolic syndrome in a working population. Methods: The present study was a secondary analysis of a cross-sectional study. A total of 60,799 workers in Spain were enrolled between 2012 and 2016, of which 50% were randomly assigned to the derivation cohort and the remainder to the validation cohort. Participants' demographics and anthropometric variables were entered into least absolute shrinkage and selection operator (LASSO) regression for the selection of variables. Subsequently, multivariable logistic regression was performed to develop the predictive model and a nomogram. The discrimination ability, calibration curve analysis and decision curve analysis of the nomogram was evaluated. Internal validation of the model was also performed. Results: There were 2725 (9.0%) participants diagnosed with metabolic syndrome in the derivation cohort and 2762 (9.1%) participants in the validation cohort. Six variables (age, smoking, body fat percentage, waist circumference, systolic blood pressure and diastolic blood pressure were included in the nomogram. The area under the curve was 0.901 (95% confidence interval (CI) 0.895-0.906) and 0.899 (95% CI 0.894-0.905) for the predictive and internal validation, respectively. Furthermore, decision curve analysis showed that if the threshold probability of metabolic syndrome is less than 72.0%, application of this nomogram can benefit more than either the treat-all or treat-none strategies. Conclusions: An anthropometry-based nomogram for predicting metabolic syndrome in a working population was developed that incorporates reliable non-invasive anthropometric features to facilitate health counselling and self-risk assessment of developing metabolic syndrome.
Introduction
Metabolic syndrome (MetS) represents a constellation of metabolic anomalies, predominantly characterised by abdominal obesity, hypertension, atherogenic dyslipidemia, hyperglycaemia and insulin resistance. [1] [2] [3] With the exponential increase in the prevalence of overweight and obesity worldwide, MetS has emerged as a serious clinical and public health challenge. 2 During recent decades, the reported prevalence of MetS in adults varied from 25.0% to 33.0%, with increased prevalence in advanced ages among different cohort studies. 3 In the United States, the age-adjusted overall prevalence of MetS was estimated to be 22.9% for adults aged 20 years and older in 2009 to 2010 by the National Health and Nutrition Examination Survey (NHANES). 4 Moreover, MetS is associated with an increased risk of several diseases and is known to confer a five-fold increased risk of developing type 2 diabetes mellitus and a two-fold increased risk of cardiovascular disease (CVD). 3 Although there are several different sets of criteria to diagnose MetS, variables that are necessarily included are anthropometric indices (the measurements of the size and proportions of the human body), including waist circumference, body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP) and waist to hip ratio; biochemical parameters such as high-density lipoprotein (HDL) cholesterol, triglycerides and fasting plasma glucose. [5] [6] [7] In addition, body fat percentage, a body shape index, waist to height ratio and body adiposity index have also been analysed as MetS-associated anthropometric variables in several studies. [8] [9] [10] [11] In general, these anthropometric indices are primarily obtained from occupational health nursing or primary healthcare nursing; therefore, individuals may benefit from an early proposal provided by nurses and health visitors based on an anthropometry-based predictive model.
As appropriate lifestyle adjustments and risk factor modifications remain the mainstay of treatment for MetS; the early identification and diagnosis of MetS are highly desirable for possible risk stratification. Therefore, the aim of the present study was to develop and validate an anthropometry-based nomogram for predicting MetS in a working population.
Methods

Study population
A total of 60,799 participants working in different economic sectors (e.g. public administration and health services) in Spain were enrolled between 2012 and 2016. 8 These workers (aged 20-70 years) volunteered to participate in this study and they were randomly selected by using a random number table during their work health periodic assessments. 8 Nine per cent of the subjects met the diagnostic criteria for MetS, as defined by the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III), of which the diagnosis of MetS was established when three of the following five were presented: (a) obesity (waist circumference ⩾102 cm in men or ⩾88 cm in women); (b) triglycerides of 150 mg/dl or greater; (c) HDL-cholesterol less than 40 mg/dl in men or less than 50 mg/dl in women; (d) BP of 130/85 mmHg or greater; (e) fasting plasma glucose of 100 mg/dl or greater. 5 In the present study, the dataset was randomly divided into the derivation and the validation cohort at a 1:1 ratio. This study was a secondary analysis of a cross-sectional study, and in the previously published article, 8 Manuel and colleagues clearly stated that the study protocol complied with the Declaration of Helsinki, and informed consent was obtained from all participants. The used data in this secondary analysis were obtained from a public database (www.Datadryad.org) that permits users to freely download raw data. The authors of the original study have waived all copyright and related ownership of these data on this public database.
Anthropometry variables collection
For this cohort study, anthropometric data, which included gender, age, smoking, SBP, DBP, waist circumference, BMI, waist to height ratio, body fat percentage (calculated as body fat percentage = 1.2 × (BMI) + 0.23 × age (years) − 10.8 × gender (male, 1; female, 0) − 5.4), and a body shape index (calculated as a body shape index = waist circumference/ ((BMI) 2/3 (height) 1/2 )) were carefully recorded. 8 All the anthropometric measurements were taken by specifically trained operators and the average of three measurements was taken. BP was measured three times consecutively in the supine position at one-minute intervals between each measurement and the averages were recorded. The recommendations contained in the manual International Standards for Anthropometric Assessment (International Society for the Advancement of Kinanthropometry) were followed in the present study. 8 
Statistical analysis
The baseline characteristics of the participants were summarised. Continuous data are expressed as mean values ± standard deviation, and categorical data are expressed as number and percentage. The unpaired t-test or Pearson's chisquared test was performed between two groups for comparison. The least absolute shrinkage and selection operator (LASSO) method and multicollinearity test were performed to select the most significant predictive variables. Logistic regression with a stepwise strategy was applied by using a likelihood ratio test with Akaike's information criterion as the stopping rule for developing the model. Accordingly, a nomogram was constructed to measure the predictor variables. The discrimination performance of the model was evaluated based on discrimination ability as determined by the area under the receiver operating characteristic (ROC) curve. Calibration curves were plotted to assess the calibration of the nomogram accompanied with the Hosmer-Lemeshow test. The clinical utility of the model was assessed by decision curve analysis (DCA). 12 All statistical analyses were performed using R statistical software (version 3.5.1). A P value less than 0.05 was considered statistically significant.
Results
In the derivation cohort and validation cohort, 2725 (9.0%) and 2762 (9.1%) participants were diagnosed with MetS, respectively. No statistically significant differences were observed for anthropometric variables between the two cohorts as assessed by univariate analysis. Patients' baseline characteristics and anthropometric measurements are shown in Table 1 .
Of the 10 anthropometric variables analysed, seven variables were filtered based on non-zero coefficients as calculated by the LASSO regression analysis using the one standard error above the minimum criterion ( Figure 1 ). The selected variables included age, smoking, body fat percentage, waist circumference, waist to height ratio, SBP and DBP. However, the variable of waist to height ratio was removed from the collinear selection. Subsequently, the six predictors above (excluding waist to height ratio) were entered into a multivariable logistic regression analysis to establish a predictive model.
The ROC analysis yielded an area under the curve (AUC) of 0.901 (95% CI 0.895-0.906) and 0.899 (95% CI 0.894-0.905), respectively, for the predictive and internal validation models ( Figure 2 ), which indicated that the discrimination performance was favourable. To facilitate the clinical utility of the model, a nomogram was constructed ( Figure 3 ), providing a quantitative tool to predict the probability of MetS in the working population.
The Hosmer-Lemeshow test yielded a non-significant value (P=0.360), indicating that the model was well calibrated. The E max and E avg values for the model were 0.081 and 0.005, respectively (Figure 4 ), which suggested that there was no departure from a perfect fit between prediction and observation.
AS is shown in Figure 5 , DCA revealed that if the threshold probability of MetS is less than 72.0%, application of this nomogram to predict MetS risk within the working population would add more benefit than either the treat-all or the treat-none strategies.
Discussion
In the present study, we developed and validated a comprehensive and convenient diagnostic nomogram for the prediction of MetS in a working population. This nomogram incorporated six significant potential anthropometric predictors (age, smoking, body fat percentage, waist circumference, SBP and DBP). The nomogram exhibited satisfactory discriminatory ability (AUC 0.901) and provided an excellent concordance when applied to the internal validation cohort, which indicated remarkable clinical applicability of the nomogram for MetS. The calibration plots revealed an excellent calibration, and DCA showed a positive net benefit of a nomogram for the prediction of MetS in the study cohort. Due to its high prevalence and high associated risk, MetS has become a major and escalating public health concern worldwide over the past few decades. 3 The reported prevalence of MetS ranges from 25.0% to 33.3% depending on the diagnostic criteria used, age, gender, ethnic background, the region and socioeconomic status. 3 Alarmingly, a study on data derived from nine population studies performed including six European countries identified 41.0% of men and 38.0% of women aged 47-71 years with MetS according to the International Diabetes Federation (IDF) waist circumference thresholds. 13 As revealed by NHANES the age-adjusted overall prevalence of MetS in adults 20 years and older in the US was 22.9% in 2009 to 2010, while in Korea, the reported prevalence rate was 25.0% in 1998 to 2008. 4 In addition, a cross-sectional survey among adults aged 18 years and older in China reported that the prevalence of MetS was 14.4% in The proposed nomogram for predicting metabolic syndrome (MetS) in the working population and its algorithm. First, find point for each predictor of an individual on the uppermost rule; then add all points together and find the total points on the penultimate rule below. The corresponding predicted probability of developing MetS could be found on the lowest rule. For example, assume there was a 40-year-old smoking worker who has a body fat percentage of 15, a waist circumference of 110 cm, a systolic blood pressure (SBP) of 140 mmHg and a diastolic blood pressure (DBP) of 90 mmHg. Correspondingly, this worker's nomogram calculated the risk of developing MetS at approximately 50% (nomogram calculations are as follows: 40-year-old, which corresponds to 10 points; smoking = 1, which corresponds to 5 points; body fat percentage = 15, which corresponds to 5 points; waist circumference = 110 cm, which corresponds to 55 points; SBP = 140 mmHg, which corresponds to 18 points; DBP = 90 mmHg, which corresponds to 10 points; this equals 103 total points, corresponding to the probability of MetS of approximately 50%. Codes annotation: smoking: 0, no; 1, yes. 2013 to 2014. 14 Overall, these surveys indicated a high prevalence of MetS in adults.
As lifestyle modifications and risk factor treatment remain the mainstay of treatment for MetS, the early identification and early diagnosis of MetS becomes crucial. 3 However, in the working population, individuals are more likely to ignore the prevention of the disorder if they have not yet encountered diagnostic criteria for MetS; however, these could still be classified as 'pre-MetS'. Consequently, a quantitative tool for assessment of the prediction of MetS is highly significant. Several previous studies focused on the prediction of MetS. In a cohort study with 636 workers for derivation and 550 for validation, Romero-Saldaña et al. proposed a clinical decision tree for the screening of MetS based on two anthropometric variables including waist to height ratio and BP. 15 The decision tree was configured from the waist to height ratio (⩾0.55) and hypertension (BP ⩾128/85 mmHg), with a high sensitivity (91.6%) and specificity (95.7%) obtained. In addition, the authors found that the probability of developing MetS reached 61.7% in workers with both waist to height ratio of 0.55 or greater and BP of 128/85 mmHg or greater. 15 Although the sample size was small and clinical utility and calibration evaluations were not performed, the study reveals that anthropometric variables have good predictive power in predicting MetS.
In addition, Kroon et al. identified MetS without including blood biochemical investigations by constructing a decision tree using BMI, waist circumference and BP from 642 subjects (aged 18-28 years). 16 Similarly, Miller et al. also developed a preliminary detection algorithm for MetS by using anthropometry (waist circumference) and blood variables (triglycerides, HDL-cholesterol and glucose) from 745 adults aged 20-39 years in 2014. 17 However, neither of these studies had a large sample size and both focused on young adults, which could not be considered as completely representative of the age range of the working population. Moreover, the algorithms used in the studies above failed to measure and predict risk factors that contribute to MetS quantitatively.
A nomogram is a graphical representation of a complex mathematical formula and it generates an individual numerical probability of a clinical outcome by integrating valuable The DCA is used for assessing if nomogramassisted decisions improve patient outcomes. The red solid line represents the nomogram, and it shows that when the threshold probability of developing metabolic syndrome (MetS) is less than 72.0%, application of this nomogram would add more net benefit than either the treat-all or the treat-none strategies. For example, assume there were 100 workers using the proposed nomogram. If the threshold probability of developing MetS was 20% (the corresponding value on the horizontal coordinate is 0.2) (i.e. the workers would opt for intervention if their probabilities of MetS were >20%), then 45 (the corresponding value on the vertical coordinate is 0.45) workers can benefit from the 100 workers who use the nomogram, without harming the interests of the remaining 55 workers (i.e. when 100 workers use the nomogram to decide whether to take interventions, the added net benefit is 45% more than either the treat-all or the treat-none strategies; similarly, when taking the risk threshold of 40% as the cut-off value, the added net benefit would be approximately 23%). prognostic or determinant variables. 18 Nomograms are useful visualisation tools for predictive models that were applied to optimise the predictive accuracy of an individual prognosis. Moreover, prognostic nomograms exhibit numerous advantages including good accuracy, user-friendliness and comprehensibility, facilitating numerous applications in clinical practice. 19 Of note, due to the statistical basis of the construction of nomograms, it is necessary to evaluate the evidence supporting their use before using them, such as assessing their discriminatory ability, calibration and clinical utility. 19 In the present study, a nomogram for the prediction of MetS in the present study was constructed and validated based on six predictors, including age, smoking, body fat percentage, waist circumference, SBP and DBP. These variables were selected on the basis of the results of LASSO regression analysis and their association with the risk of developing MetS reported in previous studies. 8, 15 The LASSO method is recognised to surpass the method of predictor's selection based on the strength of their univariable association with the actual outcome. 20, 21 This panel of six predictors is non-invasive, inexpensive and self-measurable. In the proposed model, the variable of gender shows little predictive value, and in order to avoid over-fitting of the model, this variable was not involved in the nomogram. The proposed nomogram exhibited adequate discrimination ability (AUC 0.901; 95% CI 0.895-0.906) and excellent calibration (E max 0.081, E avg 0.005, P>0.05). Moreover, DCA demonstrated its clinical applicability. 19, 22 In particular, when the threshold probability of developing MetS of an individual is less than 72.0%, using this nomogram to predict MetS would provide more benefit than either the treat-all or the treat-none strategies. Thus, the proposed nomogram may facilitate individuals to quantify their risk of developing MetS.
Several limitations of this study are worth mentioning. First, this nomogram was constructed based on the Caucasian population, as ethnic differences are associated with the prevalence of MetS; whether this nomogram applies to workers of other ethnicities requires further validation. Second, the NCEP-ATP III diagnostic criteria were adopted for detecting MetS in this study; therefore, this nomogram is only applicable to predict the MetS risk as defined by NCEP-ATP III. For example, another widely used definition for diagnosing MetS was proposed by IDF in 2005. 3 The IDF criteria were similar to the National Cholesterol Education Program definition except for the waist circumference threshold, which is lower for Europoids than that in the NCEP-ATP III criteria. Since the variable of waist circumference included in the proposed nomogram was based on the NCEP-ATP III diagnostic criteria, the risk of developing MetS evaluated by the nomogram would be underestimated if the IDF criteria are used for diagnosing MetS. Third, some potential variables, such as educational level, family history of obesity, drug use (lipid-lowering, hypotension or hypoglycaemic drug) were not analysed as data for these variables were not available in the original data. Nevertheless, despite these limitations, the present study developed a useful nomogram for predicting the risk of developing MetS with a high accuracy.
Conclusions
An anthropometry-based nomogram for predicting MetS in a working population was developed, which incorporates reliable non-invasive anthropometric features to facilitate health counselling and self-risk assessment of developing MetS. The proposed nomogram exhibited adequate discriminatory ability and remarkable clinical applicability for the early identification of variables and risk factors for the diagnosis of MetS.
Implications for practice
• • An anthropometry-based nomogram for predicting metabolic syndome was constructed, which incorporates six significant potential anthropometric predictors (age, smoking, body fat, waist circumference, systolic blood pressure and diastolic blood pressure). • • The proposed nomogram exhibited adequate discriminatory ability and remarkable clinical applicability for the early identification and early diagnosis of metabolic syndrome. • • The proposed nomogram facilitates health counselling and self-risk assessment of developing metabolic syndrome in the working population.
